ただし、追加料金で日本語のレポートが入手できる場合もある。
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cosmetic Surgery Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Procedure
6.1 Surgical Procedures
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Breast Augmentation
6.1.2.2 Liposuction
6.1.2.3 Eyelid Surgery
6.1.2.4 Abdominoplasty
6.1.2.5 Rhinoplasty
6.1.2.6 Others
6.1.3 Market Forecast
6.2 Non-Surgical Procedures
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Botulinum Toxin
6.2.2.2 Hyaluronic Acid
6.2.2.3 Hair Removal
6.2.2.4 Nonsurgical Fat Reduction
6.2.2.5 Photo Rejuvenation
6.2.2.6 Others
6.2.3 Market Forecast
7 Market Breakup by Gender
7.1 Female
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Male
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Age Group
8.1 13 To 29
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 30 To 54
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 55 and Above
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by End User
9.1 Ambulatory Surgical Facility
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospitals and Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 Drivers, Restraints, and Opportunities
11.1 Overview
11.2 Drivers
11.3 Restraints
11.4 Opportunities
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 AbbVie Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Alma Laser (Shanghai Fosun Pharmaceutical(Group)Co. Ltd)
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Cutera Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.4 Cynosure LLC
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Genesis Biosystems Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Long Island Plastic Surgical Group PC
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Lumenis Inc (Boston Scientific Corporation)
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Sientra Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 Sinclair Pharmaceuticals Limited
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Solta Medical (Bausch Health Companies Inc.)
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Syneron Candela
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12 Teoxane Laboratories
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.